Abbott Laboratories is a leading healthcare and research company having a presence in more than 160 countries worldwide. Over 14 million people around the world use Abbott’s medicines every day. It is the world’s leading company in glucose testing for diabetes. With over 130 years in business, Abbott has become the worldwide leader in adult nutrition and blood screening. It enjoys a leadership position in virtually every market it serves. Abbott owns a leading portfolio of innovative solutions in diabetes, cardiovascular, and neuromodulation. The company commands a large market share position in diabetic care and cardiovascular disease treatments in the developed markets. It derives nearly 60% of its revenue from developed markets and 40% from emerging markets. It is a leading pharmaceutical company in India, Russia, and across Latin America – with #1 positions in Chile, Colombia, and Peru. Abbott has four reportable segments - Established Pharmaceuticals (15% of 2018 sales), Nutritionals (25%), Diagnostics (26%), and Cardiovascular and Neuromodulation (33%) and other. Its portfolio consists of more than 1500 products across multiple therapeutic areas.
The S&P500 Dividend Aristocrats is the best list for filtering dividend stocks. This should be your starting point to create your core portfolio. Why should it be part of your core portfolio? It’s simple, the companies in the list must … Read more
Healthcare can be a profitable sector to have in your portfolio. Any dividend growth investor should consider having at least 1 healthcare dividend stocks. As a market, the healthcare industry is highly regulated and not easy to get into but … Read more